Skip to Main Content

11,561

Views

25

CrossRef citations to date

0

Altmetric

Drug evaluation

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis

James F. Howard Jr.a Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC, USACorrespondence[email protected]
View further author information

,

John Vissingb Department of Clinical Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkView further author information

,

Nils E. Gilhusc Department of Clinical Medicine, University of Bergen and Haukeland University Hospital, Bergen, NorwayView further author information

,

M. Isabel Leited Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UKView further author information

,

Kimiaki Utsugisawae Department of Neurology, Hanamaki General Hospital, Hanamaki, Iwate, JapanView further author information

,

Petra W. Dudaf UCB Pharma, Cambridge, MA, USAView further author information

,

Ramin Farzaneh-Farf UCB Pharma, Cambridge, MA, USAView further author information

,

Hiroyuki Muraig Department of Neurology, International University of Health and Welfare, Narita, Chiba, JapanView further author information

&

Heinz Wiendlh Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, GermanyView further author information